WeLose is a health-tracking app for individuals on GLP-1 medications, providing dose logging and medication half-life calculations on iOS.
The App DNA
What makes this app unique?
Users require a way to visualize the decay of semaglutide or tirzepatide in their system to maintain adherence, a need standard weight-tracking apps do not address.
For Individuals prescribed GLP-1 medications like semaglutide or tirzepatide requiring specialized tracking.
What does it look like?
Key features
Calculates active medication levels based on semaglutide and tirzepatide half-lives.
Aggregates logging and consistency into a single metric to gamify adherence.
Synchronizes data across devices, gated behind a Pro tier.
How much does it cost?
The freemium model gates multi-device sync and historical data imports behind a Pro tier while keeping core GLP-1 tracking free.
Velocity
Maintenance developmentUX improvementsperformanceShow more...
WeLose: GLP-1 Weight Tracker currently operates on a maintenance cadence, with the latest release arriving 14 days ago. Development is focused on incremental UX improvements and technical stability, such as refining the BMI chart and fixing logging interface issues. There is no evidence of a live-ops strategy or high-frequency feature deployment. The current pace suggests a stable, low-intensity development cycle aimed at polishing existing functionality.
Who built it?
User Sentiment
What do users think recently?
Fresh user feedback skews frustrated. Users appreciate tracking medication half-life and active dosage levels provides helpful insights for treatment management and clean and simple interface design makes the initial weight tracking experience intuitive for new users.
How are ratings & reviews evolving?
What users say, by theme
- Tracking medication half-life and active dosage levels provides helpful insights for treatment management
- Clean and simple interface design makes the initial weight tracking experience intuitive for new users
- Keyboard overlay prevents users from accessing the save button, rendering the app unusable for data entry
42 of 42 recent reviews analyzed · high confidence · Frustrated overall
Read the full review analysisUnlock 2 more frustration themes and 2 user requests, each backed by review evidence.
Access the full report for freeCompetition
Competitive landscape for WeLose: GLP-1 Weight Tracker
How's the Health & Fitness market?
WeLose occupies a niche in the Health & Fitness category by anchoring its value on GLP-1 specific half-life calculations rather than general weight logging. The current 4.7-star rating is vulnerable to erosion due to unresolved data-loss complaints reported in the latest version.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for WeLose: GLP-1 Weight Tracker
Where is it heading?
The market for specialized GLP-1 tracking is nascent, and WeLose holds an early advantage through its medication-specific calculators. However, the current maintenance-mode cadence is insufficient to resolve critical data-loss bugs, which will likely lead to a decline in user sentiment and retention as more reliable competitors enter the space.
- Persistent data loss during updates erodes user trust, which will likely accelerate churn among long-term, high-value users.
- The GLP-1 specific decay calculator remains a unique differentiator that keeps the app relevant despite technical instability.
The SWOT
- GLP-1 compound decay calculator provides specialized utility for treatment management
- Performance score gamifies adherence for medication protocols
- Add waist measurement tracking to satisfy user requests
- Implement side-effect logging to increase daily engagement
Next best moves
Rebuild local data-persistence layer because data loss during updates is the top churn risk → stabilize long-term retention
+ 1 more prioritized moveThe counter-intuitive read
The app's high rating is a lagging indicator…
Read the full takeSince the last report: WeLose shifted from a 'declining' to a 'mixed' outlook, as the app's specialized GLP-1 utility continues to provide a competitive anchor despite persistent technical failures. The focus has moved toward addressing data-persistence and calculation accuracy as the primary barriers to retention.
Bottom line
WeLose must prioritize data stability over new feature development, as the current loss of historical records during updates invalidates the app's core value proposition of long-term progress tracking.
Unlock 3 critical frictions, 2 market threats, 1 more prioritized move and the analyst’s take.
Access the full report for freeSources
- [1] App Store, source
Report last updated